Startup India Government of India
Pharmbrium Pharmaceuticals Private Limited
Pharmbrium Pharmaceuticals Private Limited - chemicals in New Delhi, Delhi, India. Directors, charges & compliance details.
Revenue · FY 2023
₹2.04 Lakh
▲ 17% YoY
Net loss · FY 2023
₹24,871
Net margin -12.2%
EBITDA · FY 2023
-₹1,153
EBITDA margin -0.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
5
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Pharmbrium Pharmaceuticals Private Limited
Data last updated:
Pharmbrium Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 29 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2021PTC380691.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Amit Rana and Gurpreet Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. Ss – 46 Aditya Mega Mall C Bd Near Cross River Mall Shahdara, New Delhi, Delhi, India – 110032.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.04 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net loss of ₹24,871 (net margin -12.2%) and EBITDA of -₹1,153 (EBITDA margin -0.6%).
Pharmbrium Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0015214).
Company details
CIN U24299DL2021PTC380691
Registration Number 380691
Incorporation Date 29 April 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0015214
Key People
Vineet Kumar Sharma Additional Director Shailender Singh Additional Director Amit Rana Director Recognitions & Rankings of Pharmbrium Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-02-0015214
Contact details
Pharmbrium Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressOffice No. Ss – 46 Aditya Mega Mall C Bd Near Cross River Mall Shahdara, New Delhi, Delhi, India – 110032
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
Comprehensive company report
Pharmbrium Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Pharmbrium Pharmaceuticals Private Limited
FY 2025 filings availablePharmbrium Pharmaceuticals Private Limited reported revenue of ₹2.04 Lakh (up 17% YoY) for FY 2023.
Revenue · FY 2023
₹2.04 Lakh ▲ 17%
Net loss · FY 2023
₹24,871 margin -12.2%
EBITDA · FY 2023
-₹1,153 margin -0.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
EBITDA CAGR growth
1 year
▲ 99%
Revenue rose 17% in the latest year. EBITDA rose 99% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1,153 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹24,871 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -0.6% | |
| Net Profit Margin | -12.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Pharmbrium Pharmaceuticals Private Limited, buy the company report.
Board of directors of Pharmbrium Pharmaceuticals Private Limited
Pharmbrium Pharmaceuticals has 5 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vineet Kumar Sharma | Additional Director | 01 Jun 2021 | 5 Years 4 Months | Current |
| Shailender Singh | Additional Director | 01 Jun 2021 | 5 Years 4 Months | Current |
| Amit Rana | Director | 29 Apr 2021 | 5 Years 6 Months | Current |
| Gurpreet Singh | Director | 29 Apr 2021 | 5 Years 6 Months | Current |
| Jatin Parashar | Director | 29 Apr 2021 | 5 Years 6 Months | Current |
Peer comparison
Pharmbrium Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zyshak Pharmaceuticals Private Limited | ₹2.06 Lakh (FY 2020) | -98.0% | Mumbai, Maharashtra, India | |||
| Hajare Lal Mitro Pharmaceuticals Private Limited | ₹2.05 Lakh (FY 2024) | Bankura, West Bengal, India | ||||
| Pipal Pharmaceuticals Private Limited | ₹2.05 Lakh (FY 2018) | -78.0% | Patna, Bihar, India | |||
| Viprans Drug and Pharmaceuticals Private Limited | ₹2.04 Lakh (FY 2022) | 121.0% | Bhopal, Madhya Pradesh, India | |||
| As Pharmaceuticals (OPC) Private Limited | ₹2.04 Lakh (FY 2021) | 0.0% | Varanasi, Uttar Pradesh, India | |||
| Pharmbrium Pharmaceuticals Private Limitedthis company | ₹2.04 Lakh (FY 2023) | -₹24,871 | -12.2% | 17.0% | New Delhi, Delhi, India | |
| Indmed Pharmaceuticals Limited | ₹2.01 Lakh (FY 2018) | -78.0% | Indore, Madhya Pradesh, India | |||
| Sandex Pharmaceuticals Private Limited | ₹2 Lakh (FY 2025) | Karunagappally, Kerala, India | ||||
| Rokson Pharmaceuticals Private Limited | ₹2 Lakh (FY 2024) | 300.0% | Nagpur, Maharashtra, India | |||
| Neosun Pharmaceuticals Private Limited | ₹2 Lakh (FY 2025) | -59.0% | Aurangabad, Maharashtra, India | |||
| Human Food Chemical and Drug Pharmaceuticals Private Limited | ₹1.99 Lakh (FY 2021) | 71.0% | Ghazipur, Uttar Pradesh, India |
To see the full peer comparison of Pharmbrium Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pharmbrium Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmbrium Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Pharmbrium Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Pharmbrium Pharmaceuticals Private Limited has 5 board changes on record since 2021: 5 appointments. The latest: Shailender Singh was appointed as Additional Director on 01 Jun 2021.
AGM
Pharmbrium Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pharmbrium Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Shailender Singh was appointed as Additional Director.
Appointed
Vineet Kumar Sharma was appointed as Additional Director.
Appointed
Amit Rana was appointed as Director.
Appointed
Gurpreet Singh was appointed as Director.
Appointed
Jatin Parashar was appointed as Director.
Incorporation
29 Apr 2021
Pharmbrium Pharmaceuticals Private Limited was registered on 29 Apr 2021 with Roc Delhi I & aged 5 years 6 months as per MCA records.
Frequently asked questions
Pharmbrium Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 29 April 2021 (5+ years old) and is registered under CIN U24299DL2021PTC380691.
Pharmbrium Pharmaceuticals has 5 current directors:
- Vineet Kumar Sharma - Additional Director
- Shailender Singh - Additional Director
- Amit Rana - Director
- Gurpreet Singh - Director
- Jatin Parashar - Director
The latest financial statements of Pharmbrium Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Pharmbrium Pharmaceuticals is U24299DL2021PTC380691. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmbrium Pharmaceuticals was incorporated on 29 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Pharmbrium Pharmaceuticals by revenue are Zyshak Pharmaceuticals Private Limited, Hajare Lal Mitro Pharmaceuticals Private Limited, Pipal Pharmaceuticals Private Limited, Viprans Drug and Pharmaceuticals Private Limited, As Pharmaceuticals (OPC) Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Shailender Singh was appointed as Additional Director on 01 Jun 2021. Vineet Kumar Sharma was appointed as Additional Director on 01 Jun 2021. Amit Rana was appointed as Director on 29 Apr 2021. Pharmbrium Pharmaceuticals has 5 board changes on record in total.
Yes, Pharmbrium Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Pharmbrium Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0015214).
The registered office of Pharmbrium Pharmaceuticals is at Office No. Ss – 46 Aditya Mega Mall C Bd Near Cross River Mall Shahdara, New Delhi, Delhi, India – 110032.
Pharmbrium Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages